You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JAZZ Sale Disclosure
Gala Renee D · SEC Form 4 · Filed Sep 10, 2026
Sale
Calculated transaction value
$486.06K
Gala Renee D President & CEO
JAZZ
Jazz Pharmaceuticals
JAZZ
Transaction date
Sep 8, 2026
Public filing date
Sep 10, 2026
Filing lag
Filed 2 days later
JAZZ daily price context
Close on/before transaction
$240.07
Sep 8, 2026
First close after public filing
$245.8
Sep 11, 2026
30-day return after filing
-11.82%
Through Oct 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 2,000 shares @ $243.03
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001607737-26-000013
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$971.54K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Jazz Pharmaceuticals Plc JAZZ Current | Sale | Sep 8, 2026 | $486.06K |
| Jazz Pharmaceuticals Plc JAZZ | Disposition | Sep 8, 2026 | $485.48K |